Rates of Positive Basal Cell Carcinomas (BCCs) in Re-excisions

Completed

• Conditions: Basal Cell Carcinoma

• Registration Number: NCT01403480
• Lead Sponsor: Rambam Health Care Campus

Brief Summary

Basal Cell Carcinoma (BCC) is the most common malignant growth in the world. Treatment is primarily surgical with the goal of excising the growth in its entirety. When pathology results show that this has not been achieved, a re-excision is routinely performed. This study examines retrospectively the percentage of re-excisions of BCC that actually proved to be positive (exhibited growth) among those re-excisions performed at Rambam Healthcare Campus and Zvulun Community Medical Center during the years 2008-10.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-01
• Primary Completion: 2010-12
• Status Verified: 2011-02
• Study Completion: 2011-02
• Study First Submitted: 2011-07-26
• Study First Submitted QC: 2011-07-26
• Last Update Submitted: 2011-07-26
• Study First Posted: 2011-07-27
• Last Update Posted: 2011-07-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

All patients that underwent an incomplete BCC excision during the years 2008-2010.

Exclusion Criteria

Patients that underwent an incomplete BCC excision and were subsequently referred to undergo a MOHS procedure.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified